TRANSFORMING MDR-TB TREATMENT: EVIDENCE FOR SHORTER, SAFER, AND COST-SAVING REGIMENS WITH BPAL

Background: Tuberculosis (TB) remains a major global public health challenge, with multidrug-resistant TB (MDR-TB) contributing substantially to poor outcomes. Conventional regimens span 18–24 months, leading to limited adherence and treatment success. Shorter treatment regimens (STRs), such as the...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолч:	Rivaldo Heru Setiawan
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Faculty of Medicine, Universitas Diponegoro 2026-02-01
Цуврал:	Jurnal Kedokteran Diponegoro
Нөхцлүүд:	bpal regimen, drug-resistant tuberculosis, short-course tb treatment, cost-effectiveness
Онлайн хандалт:	https://ejournal3.undip.ac.id/index.php/medico/article/view/52974
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!